A large number of publications on diverse topics is produced by the biological standardization programme of WHO. These include:
- Written reports of the proceedings and conclusions of consultations and other meetings are available shortly after its conclusion.
- Guidance documents which appear on the WHO Biologicals website prior to being published in the reports of the Expert Committee on Biological Standardization (ECBS) in the Technical Report Series (TRS).
- Biological standardization study reports (BS documents) which serve as the basis for the establishment of physical reference materials by the Expert Committee (ECBS) are published.
The rapid appearance of such documents in electronic form conform with WHO's policy of impartial and evidence-based decision making. The documents posted on this site represent however, only a part of the total work of WHO in the quality control and utilization medicines, and additional information can be obtained in the home pages of the contributing areas. Paper copies of many of these documents are also available for purchase from the document centers listed in the links section below.
Links to meeting reports, the Technical Report Series, and the reference preparations are provided on individual topic pages. These can be found by using the navigational tabs on the left side of each page of this site.
Paper copies of a selected number of publications may be purchased from WHO:
BS2285 WHO Guidelines on management of blood and blood components as essential medicines
BS2285 Comment Form
BS2280 Labelling information of inactivated Influenza vaccines for use in pregnant women
BS2280 Comment Form
BS2283 WHO Guidelines on estimation of residual risk of HIV, HBV or HCV infections via cellular blood commponents and plasma
BS2283 Comment Form
BS2284 WHO Manual for the preparation of secondary reference materials for in vitro diagnostic assays designed for infectious disease nucleic acid or antigen detection: Calibration to WHO International Standards
BS2284 Comment Form
BS2279 Guidelines on the quality, safety and efficacy of Ebola vaccines
BS2279 Comment Form
BS2287 Guidelines on Clinical evaluation of vaccines: regulatory expectations
BS2287 Comment Form
BS2288 Human Challenge Trials: scientific and regulatory considerations
BS2288 Comment Form
BS2289 Guidelines on regulatory preparedness for licensing human pandemic influenza vaccines in non-vaccine-producing countries
BS2289 Comment Form
BS2290 Guidelines on evaluation of monoclonal antibodies as similar biotherapeutic products (SBPs)
BS2290 Comment Form
- Expert Committee on Biological Standardization (ECBS) 17 - 21 October 2016
Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971